Cargando…

Distinct mechanisms by which two forms of miR-140 suppress the malignant properties of lung cancer cells

In this study we attempted to determine the molecular mechanisms underlying the two mature products of pre-miR-140 (3p and 5p) in malignant properties of lung cancer cells. The differential expression of the two forms of miR-140 in both NSCLC tissues and cell lines was determined by quantitative rea...

Descripción completa

Detalles Bibliográficos
Autores principales: Flamini, Valentina, Dudley, Ed, Jiang, Wen G., Cui, Yuxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284864/
https://www.ncbi.nlm.nih.gov/pubmed/30559931
http://dx.doi.org/10.18632/oncotarget.26356
_version_ 1783379383192387584
author Flamini, Valentina
Dudley, Ed
Jiang, Wen G.
Cui, Yuxin
author_facet Flamini, Valentina
Dudley, Ed
Jiang, Wen G.
Cui, Yuxin
author_sort Flamini, Valentina
collection PubMed
description In this study we attempted to determine the molecular mechanisms underlying the two mature products of pre-miR-140 (3p and 5p) in malignant properties of lung cancer cells. The differential expression of the two forms of miR-140 in both NSCLC tissues and cell lines was determined by quantitative real-time PCR (qRT-PCR). The effects of the miR-140 mimics on the malignant properties of lung cancer cells were evaluated using invasion assay, adhesion assay, tubule formation assay and metabolite profiling. Biotin-miRNA pulldown and transcriptome profiling by RNA-seq were utilized to distinguish their mRNA targets of the miR-140 strands. Their downstream signalling pathways were unveiled using a high-throughput antibody array. Although both strands of the miR-140 are downregulated in the NSCLC, miR-140-3p is more predominant compared to miR-140-5p in lung cancer cell lines. Both miR-140 mimics suppress the invasion of lung cancer cells and the inhibitory effect of the miR-140 on adhesion is cell-dependent. Tumor conditioned media from A549 cells after treatment with miR-140-3p mimic reduce the tubule formation ability of the endothelial cells. Metabolite profiling indicates the alteration of glycine in both lung cancer cells following treatment with miR-140 mimics. The data from the RNA-sequencing and antibody array indicate that two miR-140 strands present different targeting and signalling profiles despite the existence of mutual targets such as IGF1R and FOS. In conclusion, two forms of miR-140 both suppress the malignant properties of lung cancer cells but through distinct and multiple mechanisms.
format Online
Article
Text
id pubmed-6284864
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-62848642018-12-17 Distinct mechanisms by which two forms of miR-140 suppress the malignant properties of lung cancer cells Flamini, Valentina Dudley, Ed Jiang, Wen G. Cui, Yuxin Oncotarget Research Paper In this study we attempted to determine the molecular mechanisms underlying the two mature products of pre-miR-140 (3p and 5p) in malignant properties of lung cancer cells. The differential expression of the two forms of miR-140 in both NSCLC tissues and cell lines was determined by quantitative real-time PCR (qRT-PCR). The effects of the miR-140 mimics on the malignant properties of lung cancer cells were evaluated using invasion assay, adhesion assay, tubule formation assay and metabolite profiling. Biotin-miRNA pulldown and transcriptome profiling by RNA-seq were utilized to distinguish their mRNA targets of the miR-140 strands. Their downstream signalling pathways were unveiled using a high-throughput antibody array. Although both strands of the miR-140 are downregulated in the NSCLC, miR-140-3p is more predominant compared to miR-140-5p in lung cancer cell lines. Both miR-140 mimics suppress the invasion of lung cancer cells and the inhibitory effect of the miR-140 on adhesion is cell-dependent. Tumor conditioned media from A549 cells after treatment with miR-140-3p mimic reduce the tubule formation ability of the endothelial cells. Metabolite profiling indicates the alteration of glycine in both lung cancer cells following treatment with miR-140 mimics. The data from the RNA-sequencing and antibody array indicate that two miR-140 strands present different targeting and signalling profiles despite the existence of mutual targets such as IGF1R and FOS. In conclusion, two forms of miR-140 both suppress the malignant properties of lung cancer cells but through distinct and multiple mechanisms. Impact Journals LLC 2018-11-23 /pmc/articles/PMC6284864/ /pubmed/30559931 http://dx.doi.org/10.18632/oncotarget.26356 Text en Copyright: © 2018 Flamini et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (http://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Flamini, Valentina
Dudley, Ed
Jiang, Wen G.
Cui, Yuxin
Distinct mechanisms by which two forms of miR-140 suppress the malignant properties of lung cancer cells
title Distinct mechanisms by which two forms of miR-140 suppress the malignant properties of lung cancer cells
title_full Distinct mechanisms by which two forms of miR-140 suppress the malignant properties of lung cancer cells
title_fullStr Distinct mechanisms by which two forms of miR-140 suppress the malignant properties of lung cancer cells
title_full_unstemmed Distinct mechanisms by which two forms of miR-140 suppress the malignant properties of lung cancer cells
title_short Distinct mechanisms by which two forms of miR-140 suppress the malignant properties of lung cancer cells
title_sort distinct mechanisms by which two forms of mir-140 suppress the malignant properties of lung cancer cells
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284864/
https://www.ncbi.nlm.nih.gov/pubmed/30559931
http://dx.doi.org/10.18632/oncotarget.26356
work_keys_str_mv AT flaminivalentina distinctmechanismsbywhichtwoformsofmir140suppressthemalignantpropertiesoflungcancercells
AT dudleyed distinctmechanismsbywhichtwoformsofmir140suppressthemalignantpropertiesoflungcancercells
AT jiangweng distinctmechanismsbywhichtwoformsofmir140suppressthemalignantpropertiesoflungcancercells
AT cuiyuxin distinctmechanismsbywhichtwoformsofmir140suppressthemalignantpropertiesoflungcancercells